Papers/PMID:41122831
A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder (FASD).
Journal of paediatrics and child health2026The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases sleep onset latency
Evidence strength: very limited.Findingreplicated ×10“Quantitative measures were appropriate with significant reductions in sleep onset latency (n = 6) in the melatonin condition relative to the placebo condition (p = 0.003), and bedtime resistance (n = 8) according to the CSHQ (p = 0.004).”
Quoted verbatim from A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder (FASD).. - Study
- crossover
- Participants
- 6
- Duration
- 3 weeks
- Population
- children with sleep onset delay, 'at risk' of or diagnosed with foetal alcohol spectrum disorder (FASD)
A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder (FASD).2026PMID:4112283110.1111/jpc.70224Permalink